Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR

NCT01761656 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT01761656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01761656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
Lead sponsor
Central South University
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2012
Completion date
February 28, 2014
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute non-st-segment elevation myocardial infarction, stable angina, unstable angina